Table 4.

Multivariate cox regression analysis for the impact of lnc-ZNF180-2 expression on progression-free survival, cancer-specific survival and overall survival

		P-value	Hazard ratio	95% confidence interval
Progression-free survival	lnc-ZNF180-2	0.002	0.803	0.699-0.922
	pT-stage	0.824	0.970	0.742-1.268
	pN-stage	0.471	2.793	0.171-45.663
	pM-stage	0.306	0.344	0.045-2.657
	grading	0.034	2.222	1.061-4.653
Cancer-specific survival	lnc-ZNF180-2	0.009	0.865	0.777-0.964
	pT-stage	0.871	0.979	0.761-1.260
	pN-stage	0.746	0.705	0.085-5.857
	pM-stage	0.240	1.746	0.689-4.424
	grading	0.101	1.830	0.888-3.770
Overall survival	lnc-ZNF180-2	0.012	0.871	0.782-0.970
	pT-stage	0.495	0.913	0.702-1.187
	pN-stage	0.759	0.717	0.086-5.974
	pM-stage	0.164	1.945	0.763-4.962
	grading	0.076	1.929	0.933-3.990